COS.L Regulatory News (COS)

7 November 2018

Collagen Solutions plc

("Collagen Solutions" or the "Company")

Investor presentation

Collagen Solutions Plc (AIM: COS), the developer and manufacturer of medical grade collagen-based biomaterials for use in research, diagnostics, medical devices, and regenerative medicine, announces it will hold an investor results presentation on Tuesday, 4 December 2018.

The investor event will take place at The Brand Exchange, 3 Birchin Lane, London EC3V 9BW at 4.30pm for a 4.45pm start. This will be followed by drinks and canapes, and a chance to network.

Jamal Rushdy, CEO, and Hilary Spence, CFO, will summarise the half year results and present the key financial highlights, outlook and future vision and how they plan to deliver on the Company's growth strategy.

If you would like to register to attend the investor briefing or require further information, please contact Walbrook PR on 020 7933 8780 or email collagen@walbrookpr.com.

About Collagen Solutions:

Collagen Solutions Plc is a global supplier, developer, and manufacturer of medical grade collagen, tissues, and related medical devices and components for use in regenerative medicine, medical devices and in-vitro diagnostics and research. The Company is also expanding its range of biomaterials-based finished medical devices based on its internal and acquired intellectual property for commercialisation with partners via licensing and distribution arrangements, including ChondroMimetic®. The Company's products are used in a wide variety of applications including orthopaedics, cardiovascular, dental, plastic surgery, wound healing, neurology and urology.

For more information go to: www.collagensolutions.com